Aged
Aged, 80 and over
Combined Modality Therapy
Female
Humans
Interferon-alpha
Male
Middle Aged
Multiple Myeloma
Neoplasm Recurrence, Local
Prospective Studies
Recombinant Proteins
Survival Rate
